Publikation:

Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells

Lade...
Vorschaubild

Dateien

Cherianidou_2-1l0sbytpsslu26.pdf
Cherianidou_2-1l0sbytpsslu26.pdfGröße: 5.62 MBDownloads: 20

Datum

2023

Autor:innen

Cherianidou, Anna
Kappenberg, Franziska
Seidel, Florian
Acharya, Aviseka
Papazoglou, Panagiota
Srinivasan, Sureshkumar Perumal
Hescheler, Jürgen
Peng, Luying
Sachinidis, Agapios
et al.

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Link zur Lizenz

Angaben zur Forschungsförderung

Deutsche Forschungsgemeinschaft (DFG): 427806116

Projekt

Open Access-Veröffentlichung
Open Access Gold
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Cell Death Discovery. Springer. 2023, 9(1), 321. eISSN 2058-7716. Available under: doi: 10.1038/s41420-023-01616-6

Zusammenfassung

Animal studies for embryotoxicity evaluation of potential therapeutics and environmental factors are complex, costly, and time-consuming. Often, studies are not of human relevance because of species differences. In the present study, we recapitulated the process of cardiomyogenesis in human induced pluripotent stem cells (hiPSCs) by modulation of the Wnt signaling pathway to identify a key cardiomyogenesis gene signature that can be applied to identify compounds and/or stress factors compromising the cardiomyogenesis process. Among the 23 tested teratogens and 16 non-teratogens, we identified three retinoids including 13- cis -retinoic acid that completely block the process of cardiomyogenesis in hiPSCs. Moreover, we have identified an early gene signature consisting of 31 genes and associated biological processes that are severely affected by the retinoids. To predict the inhibitory potential of teratogens and non-teratogens in the process of cardiomyogenesis we established the “Developmental Cardiotoxicity Index” (CDI 31g ) that accurately differentiates teratogens and non-teratogens to do or do not affect the differentiation of hiPSCs to functional cardiomyocytes.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690CHERIANIDOU, Anna, Franziska KAPPENBERG, Florian SEIDEL, Aviseka ACHARYA, Panagiota PAPAZOGLOU, Sureshkumar Perumal SRINIVASAN, Jürgen HESCHELER, Luying PENG, Marcel LEIST, Agapios SACHINIDIS, 2023. Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells. In: Cell Death Discovery. Springer. 2023, 9(1), 321. eISSN 2058-7716. Available under: doi: 10.1038/s41420-023-01616-6
BibTex
@article{Cherianidou2023-08-29Trans-67827,
  year={2023},
  doi={10.1038/s41420-023-01616-6},
  title={Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells},
  number={1},
  volume={9},
  journal={Cell Death Discovery},
  author={Cherianidou, Anna and Kappenberg, Franziska and Seidel, Florian and Acharya, Aviseka and Papazoglou, Panagiota and Srinivasan, Sureshkumar Perumal and Hescheler, Jürgen and Peng, Luying and Leist, Marcel and Sachinidis, Agapios},
  note={Article Number: 321}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/67827">
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dcterms:abstract>Animal studies for embryotoxicity evaluation of potential therapeutics and environmental factors are complex, costly, and time-consuming. Often, studies are not of human relevance because of species differences. In the present study, we recapitulated the process of cardiomyogenesis in human induced pluripotent stem cells (hiPSCs) by modulation of the Wnt signaling pathway to identify a key cardiomyogenesis gene signature that can be applied to identify compounds and/or stress factors compromising the cardiomyogenesis process. Among the 23 tested teratogens and 16 non-teratogens, we identified three retinoids including 13- cis -retinoic acid that completely block the process of cardiomyogenesis in hiPSCs. Moreover, we have identified an early gene signature consisting of 31 genes and associated biological processes that are severely affected by the retinoids. To predict the inhibitory potential of teratogens and non-teratogens in the process of cardiomyogenesis we established the “Developmental Cardiotoxicity Index” (CDI 31g ) that accurately differentiates teratogens and non-teratogens to do or do not affect the differentiation of hiPSCs to functional cardiomyocytes.</dcterms:abstract>
    <dc:creator>Sachinidis, Agapios</dc:creator>
    <dc:contributor>Seidel, Florian</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/67827"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-09-20T08:07:51Z</dc:date>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Srinivasan, Sureshkumar Perumal</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-09-20T08:07:51Z</dcterms:available>
    <dc:creator>Seidel, Florian</dc:creator>
    <dc:creator>Hescheler, Jürgen</dc:creator>
    <dc:contributor>Kappenberg, Franziska</dc:contributor>
    <dc:creator>Cherianidou, Anna</dc:creator>
    <dc:contributor>Sachinidis, Agapios</dc:contributor>
    <dcterms:issued>2023-08-29</dcterms:issued>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:contributor>Acharya, Aviseka</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Peng, Luying</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/67827/1/Cherianidou_2-1l0sbytpsslu26.pdf"/>
    <dc:contributor>Hescheler, Jürgen</dc:contributor>
    <dc:creator>Peng, Luying</dc:creator>
    <dcterms:title>Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells</dcterms:title>
    <dc:creator>Leist, Marcel</dc:creator>
    <dc:creator>Kappenberg, Franziska</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/67827/1/Cherianidou_2-1l0sbytpsslu26.pdf"/>
    <dc:creator>Srinivasan, Sureshkumar Perumal</dc:creator>
    <dc:contributor>Cherianidou, Anna</dc:contributor>
    <dc:creator>Acharya, Aviseka</dc:creator>
    <dc:language>eng</dc:language>
    <dc:creator>Papazoglou, Panagiota</dc:creator>
    <dc:contributor>Papazoglou, Panagiota</dc:contributor>
    <dc:contributor>Leist, Marcel</dc:contributor>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen